Esprolol
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Esprolol, also known as (S)-ACC-9369, is a beta blocker which was under development for the treatment of angina pectoris, anxiety disorders, and migraine. It is taken sublingually and has a rapid onset of action, short time to peak, and short duration. The drug is a prodrug of amoxolol, which is formed from esprolol via esterase enzymes. It is a selective β 1 -adrenergic receptor antagonist. Esprolol was under development by Selectus Pharmaceuticals. It reached phase 2 clinical trials for all indications prior to the discontinuation of its development in 2001.
Esprolol, also known as (S)-ACC-9369, is a beta blocker which was under development for the treatment of angina pectoris, anxiety disorders, and migraine. It is taken sublingually and has a rapid onset of action, short time to peak, and short duration. The drug is a prodrug of amoxolol, which is formed from esprolol via esterase enzymes. It is a selective β 1 -adrenergic receptor antagonist. Esprolol was under development by Selectus Pharmaceuticals. It reached phase 2 clinical trials for all indications prior to the discontinuation of its development in 2001.
See also
List of investigational anxiety disorder drugs List of investigational headache and migraine drugs
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372174197 under CC BY-SA 4.0; modifications have been made.